Onishi T, Miyai K, Kumahara Y
Nihon Naibunpi Gakkai Zasshi. 1975 Mar 20;51(3):161-5. doi: 10.1507/endocrine1927.51.3_161.
Synthetic thyrotropin-releasing hormone (TRH) has been shown to be a stimulator of prolactin release as well as of thyrotropin (TSH) release in normal man. This paper presents data concerning the effect of TRH on the PRL response in normal human subjects and in patients with thyroid diseases. Synthetic TRH (500 mug) was administered intravenously to 12 normal males, 12 normal females, 8 female patients with hyperthyroidism, and 8 female patients with primary hypothyroidism. Blood samples were taken for the determination of the serum prolactin(PRL) and thyrotropin (TSH concentrations. Serum PRL and TSH levels were determined by each specific and sensitive radioimmunoassay. The mean serum PRL level was 6.1 +/- 4.9 ng/ml (mean +/- SD) before TRH administration in normal females, and 4.9 +/- 5.0 ng/ml in normal males. The difference was not statistically significant. The serum PRL levels 15 min after TRH administration were significantly higher in females than in males (42.0 +/- 17.2 vs. 26.3 +/- 8.6 ng/ml, p smaller than 0.001). The mean serum PRL level before Trh administration in patients with hyperthyroidism was higher than in normal females (12.5 +/- 5.5 vs. 6.2 +/- 4.9 ng/ml, p smaller than 0.05), but the mean serum PRL level 30 min after TRH was lower in cases of hyperthyroidism than in normal females (14.3 +/- 5.0 vs. 44.1 +/- 13.7 ng/ml, p smaller than 0.05). The mean serum PRL level before TRH administration in primary hypothyroidism was significantly higher than in normal females (37.6 +/- 29.0 vs. 6.2 +/- 4.9 ng/ml, p smaller than 0.05) and serum PRL level after TRH was also higher in hypothyroidism than in normal females (132.8 +/- 83.4 vs. 42 +/- 17.2, p smaller than 0l05). There was a positive correlation between the maximum increase in serum PRL concentration above the base line (...PRL) and the increment in serum TSH (...TSH) after TRH administration in these subjects. In conclusion, the PRL response to TRH was greater in females than in males, abolished in hyperthyroidism and exaggerated in primary hypothyroidism. These results indicate that the thyroid hormone concentration influences the PRL response to TRH as well as TSH response.
合成促甲状腺激素释放激素(TRH)已被证明在正常男性中是催乳素释放以及促甲状腺激素(TSH)释放的刺激物。本文呈现了关于TRH对正常人类受试者和甲状腺疾病患者催乳素反应影响的数据。将合成TRH(500微克)静脉注射给12名正常男性、12名正常女性、8名甲状腺功能亢进女性患者和8名原发性甲状腺功能减退女性患者。采集血样以测定血清催乳素(PRL)和促甲状腺激素(TSH)浓度。血清PRL和TSH水平通过各自特异且灵敏的放射免疫测定法进行测定。在正常女性中,TRH给药前血清PRL平均水平为6.1±4.9纳克/毫升(均值±标准差),在正常男性中为4.9±5.0纳克/毫升。差异无统计学意义。TRH给药后15分钟,女性血清PRL水平显著高于男性(42.0±17.2对26.3±8.6纳克/毫升,p<0.001)。甲状腺功能亢进患者TRH给药前血清PRL平均水平高于正常女性(12.5±5.5对6.2±4.9纳克/毫升,p<0.05),但甲状腺功能亢进患者TRH给药后30分钟血清PRL平均水平低于正常女性(14.3±5.0对44.1±13.7纳克/毫升,p<0.05)。原发性甲状腺功能减退患者TRH给药前血清PRL平均水平显著高于正常女性(37.6±29.0对6.2±4.9纳克/毫升,p<0.05),且甲状腺功能减退患者TRH给药后血清PRL水平也高于正常女性(132.8±83.4对42±17.2,p<0.05)。在这些受试者中,血清PRL浓度高于基线的最大增加值(...PRL)与TRH给药后血清TSH增加值(...TSH)之间存在正相关。总之,女性对TRH的PRL反应大于男性,在甲状腺功能亢进时消失,在原发性甲状腺功能减退时增强。这些结果表明甲状腺激素浓度影响对TRH的PRL反应以及TSH反应。